News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
EU Approves Novartis Corporation’s Eucreas Diabetes Drug
February 25, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Feb 25 (Reuters) - The European Union approved Novartis's Eucreas diabetes pill, the Swiss drugmaker said on Monday, following its approval of Galvus, one of the two-in-one drug's ingredients.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
MORE ON THIS TOPIC
Job Trends
Recent Federal Actions Put US, Massachusetts Biotech Leadership at Risk: MassBio
May 7, 2025
·
3 min read
·
Angela Gabriel
Podcast
Trump’s US Manufacturing Push, New Vaccine Policy, Novo’s Weight Loss Pill up for FDA Review
May 7, 2025
·
1 min read
·
Heather McKenzie
FDA
Biotech Stocks Fall After FDA Names Vinay Prasad To Succeed Marks at CBER
May 6, 2025
·
3 min read
·
Heather McKenzie
GLP-1
Novo’s Wegovy Inches Closer to Becoming First FDA-Approved GLP-1 Weight-Loss Pill
May 5, 2025
·
2 min read
·
Tristan Manalac
